Infection and Reactivation of HCMV and other Herpesviridae in children with neutropenic fever after chemotherapy

Recruiting

• Conditions: malignant disease, neutropenic fever.; C00-C97; Malignant neoplasms

• Registration Number: DRKS00006152
• Lead Sponsor: Pädiatrische Hämatologie und Onkologie, UK Essen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-05-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Chemotherapy due to malignant disease. Initial Diagnosis in local center.

Exclusion Criteria

BMT. Missing informed consent.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CMV Reactivation in neutropenic Fever (analysis of CMV DNA, analysis of activation of HCMV MIEP promotor through patient serum)

Secondary Outcome Measures

Name	Time	Method
Frequency of miscellaneous infections in neutropenic fever